$1.41
+0.02 (+1.44%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+904.3% upside
Low Target
$9.87
Average Target
$14.16
High Target
$18.59
Current Price
$1.41
Current
$1.41
$1.41
Target
$14.16
$14.16
$9.87
$14.16 avg
$18.59
Scenario Analysis
Bear Case
$9.87
600.0%
Low target
Base Case
$14.16
+904.3%
Avg target
Bull Case
$18.59
+1,218.4%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$3.82
-63.1% from high
52-Week Low
$0.56
+153.5% from low
Target vs 52W High
$14.16
+270.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -11.6% |
| REGN | Buy | 37 | 70% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.0% |